252 related articles for article (PubMed ID: 31626230)
21. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
de Leon J; Arranz MJ; Ruaño G
Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
[TBL] [Abstract][Full Text] [Related]
22. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacogenetics in psychiatry: how far are we from clinical application?].
Daray FM; Maffia PC; Rothlin RP; Errasti AE
Vertex; 2012; 23(104):299-309. PubMed ID: 23170302
[TBL] [Abstract][Full Text] [Related]
24. What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
de Leon J; Spina E
Expert Rev Clin Pharmacol; 2016; 9(3):351-4. PubMed ID: 26580456
[TBL] [Abstract][Full Text] [Related]
25. Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application.
Murphy LE; Fonseka TM; Bousman CA; Müller DJ
Mol Psychiatry; 2022 Jan; 27(1):593-605. PubMed ID: 34754108
[TBL] [Abstract][Full Text] [Related]
26. [Concepts applied to psychiatry pharmacogenomics].
Zorrilla Zubilete MA
Vertex; 2016 Sep; XXVII(129):383-392. PubMed ID: 28282076
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetic Tests in Psychiatry.
Bousman C; Allen J; Eyre HA
Am J Psychiatry; 2018 Feb; 175(2):189. PubMed ID: 29385827
[No Abstract] [Full Text] [Related]
28. Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?
Kirchheiner J; Seeringer A; Viviani R
Curr Pharm Des; 2010; 16(2):136-44. PubMed ID: 20205659
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics in Psychiatric Practice.
El-Mallakh RS; Roberts RJ; El-Mallakh PL; Findlay LJ; Reynolds KK
Clin Lab Med; 2016 Sep; 36(3):507-23. PubMed ID: 27514465
[TBL] [Abstract][Full Text] [Related]
30. A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease.
Sychev D; Fedina L; Poptsova M; Zateyshchikov D; Mirzaev K; Tsimbal E; Sychev I; Rastvorova T
Pharmacogenomics; 2022 Oct; 23(15):847-856. PubMed ID: 36093937
[No Abstract] [Full Text] [Related]
31. Moving Pharmacogenetics Into Practice: It's All About the Evidence!
Luzum JA; Petry N; Taylor AK; Van Driest SL; Dunnenberger HM; Cavallari LH
Clin Pharmacol Ther; 2021 Sep; 110(3):649-661. PubMed ID: 34101169
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].
Kirnichnaya KA; Sosin DN; Ivanov MV; Mikhaylov VA; Ivashchenko DV; Ershov EE; Taraskina AE; Nasyrova RF; Krupitsky EM
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4):113-125. PubMed ID: 26322366
[TBL] [Abstract][Full Text] [Related]
33. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatic tools are essential to integrating pharmacogenomics into clinical practice: lessons from neuropsychiatric disorders.
Zampatti S; Giardina E
Pharmacogenomics; 2022 Mar; 23(4):221-223. PubMed ID: 35147039
[No Abstract] [Full Text] [Related]
35. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
Morley KI; Hall WD
J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
[TBL] [Abstract][Full Text] [Related]
36. Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics.
Watanabe H; Nagano N; Tsuji Y; Noto N; Ayusawa M; Morioka I
Eur J Clin Pharmacol; 2024 Feb; 80(2):203-221. PubMed ID: 38078929
[TBL] [Abstract][Full Text] [Related]
37. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
Stingl JC; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
[TBL] [Abstract][Full Text] [Related]
38. Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology.
Hiemke C
Curr Drug Deliv; 2016; 13(3):353-61. PubMed ID: 26511090
[TBL] [Abstract][Full Text] [Related]
39. [State of the art of pharmacogenetic diagnostics in drug therapy].
Kirchheiner J; Seeringer A; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
van den Akker-van Marle ME; Gurwitz D; Detmar SB; Enzing CM; Hopkins MM; Gutierrez de Mesa E; Ibarreta D
Pharmacogenomics; 2006 Jul; 7(5):783-92. PubMed ID: 16886902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]